Clinical Trial Update: PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of single doses of Stalevo and Levodopa/Carbidopa on striatal 11C-Raclopride binding in Parkinson's disease; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa/Carbidopa (levodopa/carbidopa)
• Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Parkinson´s Disease | Phase 2 | Status: TERMINATED